Art. 15 Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…

In forcecited 3×
1.

Where the intention is to apply for a marketing authorisation in accordance with Article 7(1)(a) or (d), Article 8 or Article 30, a paediatric investigation plan shall be drawn up and submitted to the Agency with a request for agreement.

2.

The paediatric investigation plan shall specify the timing and the measures proposed to assess the quality, safety and efficacy of the medicinal product in all subsets of the paediatric population that may be concerned. In addition, it shall describe any measures to adapt the formulation of the medicinal product so as to make its use more acceptable, easier, safer or more effective for different subsets of the paediatric population.

  • Order of the President of the Court of First Instance of 24 April 2009. Nycomed Danmark ApS v Agence européenne des médicaments (EMEA).Decision

    24 Apr 2009 · 62009TO0052

  • Judgment of the General Court (Third Chamber) of 14 December 2011. Nycomed Danmark ApS v European Medicines Agency (EMA).Decision

    Articles 1, 2, 3, 6, 7, 11, 13, 15 and 16 of Regulation No 1901/2006 read as follows: ‘Article 1 This Regulation lays down rules concerning the development of medicinal products for human use in order to meet the specific therapeutic …

    14 Dec 2011 · 62009TJ0052

  • Regulation (EU) 2024/568Law

    … EUR s’applique aux demandes d’approbation d’un plan d’investigation pédiatrique introduites en vertu de l’article 15 du règlement (CE) no 1901/2006. Une dispense est accordée pour le montant total de cette redevance. La …